About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [763 citations: 101–200 of 714 articles]

Articles published in Advances in Hematology have been cited 763 times. The following is a list of the 714 articles that have cited the articles published in Advances in Hematology.

  • Angelica Horrillo, Tomas Fontela, Elena G. Arias-Salgado, Dolores Llobat, Gracia Porras, and Matilde S. Ayuso, “Generation of mice with conditional ablation of the Cd40lg gene: new insigh ts on the role of CD40L,” Transgenic Research, vol. 23, no. 1, pp. 53–66, 2014. View at Publisher · View at Google Scholar
  • Fernanda R. Godoy, Daniela de M. e Silva, Thais C. Vieira, Claudio C. da Silva, and Aparecido D. da Cruz, “Applicability of gene expression profile of childhood acute lymphoblastic l eukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goias (Brazil),” Tumor Biology, vol. 35, no. 2, pp. 1397–1402, 2014. View at Publisher · View at Google Scholar
  • X. Chang, Y. Zhu, C. Shi, and A. K. Stewart, “Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma,” Acta Biochimica et Biophysica Sinica, 2013. View at Publisher · View at Google Scholar
  • Sylwester Głowacki, and Janusz Błasiak, “Role of epigenetic modifications in pathogenesis of leukemia,” Acta Haematologica Polonica, vol. 44, no. 1, pp. 48–57, 2013. View at Publisher · View at Google Scholar
  • Anna Dmoszyńska, “Leki immunomodulujące – przełom w leczeniu nowotworów hematologicznych,” Acta Haematologica Polonica, 2013. View at Publisher · View at Google Scholar
  • Tolo Diebkilé Aïssata, Duni Sawadogo, Clotaire Nanho, Boidy Kouakou, N'dogomo Meité, N'Dhatz Emeuraude, Ayémou Roméo, Sekongo Yassongui Mamadou, Paul Kouéhion, Konan Mozart, Gustave Koffi, and Ibrahima Sanogo, “Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans,” Advances in Hematology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • Xiaoxu Huang, Wenling Zheng, Jianming Han, and Wenli Ma, “Extract Of Perilla Frutescens Inhibits Tumor Proliferation Of Hcc Via Pi3k/ Akt Signal Pathway,” African Journal Of Traditional Complementary And Alternative Medicines, vol. 10, no. 2, pp. 251–257, 2013. View at Publisher · View at Google Scholar
  • Rong Hu, Rong Zhang, Miao Miao, Ke Zhu, Wei Yang, and Zhuogang Liu, “Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma,” American Journal of Case Reports, vol. 14, pp. 292–294, 2013. View at Publisher · View at Google Scholar
  • Emine Akinci, Hakan Akilli, Zerrin Defne Dundar, Ramazan Koylu, Mustafa Polat, and Basar Cander, “A new marker for myocardial injury in carbon monoxide poisoning: T peak-T e nd,” American Journal of Emergency Medicine, vol. 31, no. 12, pp. 1651–1655, 2013. View at Publisher · View at Google Scholar
  • Ali T. Taher, Vip Viprakasit, Khaled M. Musallam, and M. Domenica Cappellini, “Treating iron overload in patients with non-transfusion-dependent thalassem ia,” American Journal of Hematology, vol. 88, no. 5, pp. 409–415, 2013. View at Publisher · View at Google Scholar
  • A. Cignetti, M. Ruella, A. Elia, V. Tassi, V. Redoglia, D. Gottardi, and C. Tarella, “Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: Description of its use in high risk patients,” American Journal of Hematology, 2013. View at Publisher · View at Google Scholar
  • Pilar Gallego, Vanessa Roldan, and Gregory Y. H. Lip, “Conventional and New Oral Anticoagulants in the Treatment of Chest Disease and Its Complications,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 4, pp. 413–421, 2013. View at Publisher · View at Google Scholar
  • Emanuele S. G. d'Amore, Carlo Visco, Andrea Menin, Barbara Famengo, Paolo Bonvini, and Elena Lazzari, “STAT3 Pathway Is Activated in ALK-positive Large B-cell Lymphoma Carrying S QSTM1-ALK Rearrangement and Provides a Possible Therapeutic Target,” American Journal of Surgical Pathology, vol. 37, no. 5, pp. 780–786, 2013. View at Publisher · View at Google Scholar
  • Malgorzata Sokolowska-Wojdylo, Aleksandra Florek, Wioletta Baranska-Rybak, Monika Sikorska, Anna Starzynska, Barbara Drogoszewska, and Adam Wlodarkiewicz, “Natural Killer/T-Cell Lymphoma, Nasal Type, Masquerading as Recalcitrant Pe riodontitis in a Patient With a Diagnosis of Wegener's Granulomatosis,” American Journal of The Medical Sciences, vol. 345, no. 2, pp. 163–167, 2013. View at Publisher · View at Google Scholar
  • Hao Wu, Hong-Bin Zou, Ying Xu, Yu-Jun Du, Jin-Yu Yu, Rong-Hua Lu, and Xiang Li, “Hepatitis C Virus-related Heat-insoluble Cryoglobulinemia and Thrombotic Mi croangiopathy,” American Journal of The Medical Sciences, vol. 346, no. 4, pp. 345–348, 2013. View at Publisher · View at Google Scholar
  • Lawrence Tim Goodnough, and Aryeh Shander, “Current Status of Pharmacologic Therapies in Patient Blood Management,” Anesthesia and Analgesia, vol. 116, no. 1, pp. 15–34, 2013. View at Publisher · View at Google Scholar
  • Steven M. Frank, Bagrat Abazyan, Masahiro Ono, Charles W. Hogue, David B. Cohen, Dan E. Berkowitz, Paul M. Ness, and Viachaslau M. Barodka, “Decreased Erythrocyte Deformability After Transfusion and the Effects of Er ythrocyte Storage Duration,” Anesthesia and Analgesia, vol. 116, no. 5, pp. 975–981, 2013. View at Publisher · View at Google Scholar
  • Guihua Wang, Junbo Hu, Cheng Chen, Rui Yang, Xiaonian Cao, Senyan Lai, Xuelai Luo, Yongdong Feng, Xianmin Xia, and Jianping Gong, “P55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-κB pathway,” Angiogenesis, vol. 16, no. 3, pp. 561–573, 2013. View at Publisher · View at Google Scholar
  • Maria Virginia Buergesser, Gabriela Gualco, Ana Diller, Yasodha Natkunam, and Carlos E. Bacchi, “Clinicopathological features of aggressive B-cell lymphomas including B-cel l lymphoma, unclassifiable, with features intermediate between diffuse larg e B-cell and Burkitt lymphomas: a study of 44 patients from Argentina,” Annals of Diagnostic Pathology, vol. 17, no. 3, pp. 250–255, 2013. View at Publisher · View at Google Scholar
  • Hu Zhou, Rongfeng Fu, Hongmei Wang, Fangfang Zhou, Huiyuan Li, Zeping Zhou, Lei Zhang, and Renchi Yang, “Immune thrombocytopenia in the elderly: clinical course in 525 patients fro m a single center in China,” Annals of Hematology, vol. 92, no. 1, pp. 79–87, 2013. View at Publisher · View at Google Scholar
  • Stefan Baumann, Friederike Kuchler, Mark Reinwald, Tobias Tenenbaum, Nicolai Haertel, Wolf-Karsten Hofmann, and Dieter Buchheidt, “Hodgkin's lymphoma in a patient with cystic fibrosis: a clinical challenge,” Annals Of Hematology, vol. 92, no. 4, pp. 571–572, 2013. View at Publisher · View at Google Scholar
  • Jayoung Lee, Seok-Goo Cho, Su-Mi Chung, Mi Ryeong Ryu, Sung Hwan Kim, Hong-Seok Jang, and Byung-Ock Choi, “Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: Single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL),” Annals of Hematology, vol. 92, no. 3, pp. 333–343, 2013. View at Publisher · View at Google Scholar
  • Giuliana Alimena, “Efficacy and safety of deferasirox in myelodysplastic syndromes,” Annals Of Hematology, vol. 92, no. 7, pp. 863–870, 2013. View at Publisher · View at Google Scholar
  • Mark Tan, Samantha Goh, and Hutan Ashrafian, “Michelangelo's John the Baptist and thalassemia,” Annals of Hematology, 2013. View at Publisher · View at Google Scholar
  • Qingqing Cai, Jason Westin, Kai Fu, Madhav Desai, Liang Zhang, Huiqiang Huang, Wenqi Jiang, Rong Liang, Zhengzi Qian, Richard E. Champlin, and Michael Wang, “Accelerated therapeutic progress in diffuse large B cell lymphoma,” Annals of Hematology, 2013. View at Publisher · View at Google Scholar
  • Yumi Ha, Duk Hyun Sung, Yoonhong Park, and Du Hwan Kim, “Brachial plexopathy due to myeloid sarcoma in a patient with acute myeloid leukemia after allogenic peripheral blood stem cell transplantation,” Annals of Rehabilitation Medicine, vol. 37, no. 2, pp. 280–285, 2013. View at Publisher · View at Google Scholar
  • Jerzy Sieńko, Agata Jasiczek, Bogusław Machaliński, Maciej Kotowski, Krzysztof Safranow, Edyta Paczkowska, Bartosz Wojciuk, Jarosław Piatek, Andrzej Ossowski, Magdalena Wiśniewska, and Marek Ostrowski, “Role of platelets in the modulation of kidney allograft recipients' immune systems,” Annals of Transplantation, vol. 18, no. 1, pp. 76–81, 2013. View at Publisher · View at Google Scholar
  • Yandun Zou, Zhixin Sheng, Hongkai Lu, and Jinming Yu, “Continuous treatment with new agents for newly diagnosed multiple myeloma,” Anti-Cancer Drugs, vol. 24, no. 5, pp. 527–533, 2013. View at Publisher · View at Google Scholar
  • Gillian Z. MacDonald, Natacha S. Hogan, Bernd Köllner, Karen L. Thorpe, Laura J. Phalen, Brian D. Wagner, and Michael R. van den Heuvel, “Immunotoxic effects of oil sands-derived naphthenic acids to rainbow trout,” Aquatic Toxicology, vol. 126, pp. 95–103, 2013. View at Publisher · View at Google Scholar
  • Bin Xu, Samuel Abourbih, Kanishka Sircar, Wassim Kassouf, Jose Joao Mansure, Armen Aprikian, and Simon Tanguay, “Enhancer of Zeste Homolog 2 Expression Is Associated With Metastasis and Ad verse Clinical Outcome in Clear Cell Renal Cell Carcinoma A Comparative Stu dy and Review of the Literature,” Archives of Pathology & Laboratory Medicine, vol. 137, no. 10, pp. 1326–1336, 2013. View at Publisher · View at Google Scholar
  • Mehmet Alp, Hakan Göker, Tulin Ozkan, and Asuman Sunguroglu, “Synthesis and cytotoxic evaluation of novel N-substituted amidino-1-hydroxybenzimidazole derivatives,” Archives of Pharmacal Research, 2013. View at Publisher · View at Google Scholar
  • R. M. Thushara, M. Hemshekhar, K. Kemparaju, K. S. Rangappa, S. Devaraja, and K. S. Girish, “Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology,” Archives of Toxicology, vol. 88, no. 2, pp. 185–198, 2013. View at Publisher · View at Google Scholar
  • Luz Tarin-Arzaga, Marisol Rodriguez-Martinez, David Gomez-Almaguer, and Andres Gomez-de-Leon, “Current Approaches for the Treatment of Autoimmune Hemolytic Anemia,” Archivum Immunologiae Et Therapiae Experimentalis, vol. 61, no. 5, pp. 385–395, 2013. View at Publisher · View at Google Scholar
  • Julio F. Marchini, Rogerio Sarmento-Leite, Carlos Gottschall, Kevin Croce, Andre Manica, Clara Manfroi, and La Hore Rodrigues, “Prevalence of High Platelet Reactivity in Aspirin-Treated Patients Referred for Coronary Angiography,” Arquivos Brasileiros De Cardiologia, vol. 100, no. 1, pp. 29–36, 2013. View at Publisher · View at Google Scholar
  • Patrick Gerardin, Adrian Fianu, Alain Michault, Corinne Mussard, Karim Boussaid, Olivier Rollot, Philippe Grivard, Somar Kassab, Eric Bouquillard, Gianandrea Borgherini, Bernard-Alex Gauezere, Denis Malvy, Gerard Breart, and Francois Favier, “Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study,” Arthritis Research & Therapy, vol. 15, no. 1, 2013. View at Publisher · View at Google Scholar
  • Mi-Hua Liu, Shun-Lin Qu, Yuan Zhang, Zhong Ren, Zhi-Han Tang, Guo-Hua Li, and Lu-Shan Liu, “Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: Atherogenesis and angiogenesis,” Atherosclerosis, vol. 229, no. 1, pp. 10–17, 2013. View at Publisher · View at Google Scholar
  • David P. Steensma, and Norbert Gattermann, “When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?,” Best Practice & Research Clinical Haematology, 2013. View at Publisher · View at Google Scholar
  • Michael Auerbach, Lawrence Tim Goodnough, and Aryeh Shander, “Iron: The new advances in therapy,” Best Practice and Research: Clinical Anaesthesiology, vol. 27, no. 1, pp. 131–140, 2013. View at Publisher · View at Google Scholar
  • Yang Xi, Dongyan Chen, Lei Sun, and Lei Li, “Characterization of zebrafish mutants with defects in bone calcification du ring development,” Biochemical and Biophysical Research Communications, vol. 440, no. 1, pp. 132–136, 2013. View at Publisher · View at Google Scholar
  • K.M. Hannan, E. Sanij, L.I. Rothblum, R.D. Hannan, and R.B. Pearson, “Dysregulation of RNA polymerase I transcription during disease,” Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol. 1829, no. 3-4, pp. 342–360, 2013. View at Publisher · View at Google Scholar
  • Bhopal Mohapatra, Gulzar Ahmad, Scott Nadeau, Neha Zutshi, Wei An, Sarah Scheffe, Lin Dong, Dan Feng, Benjamin Goetz, Priyanka Arya, Tameka A. Bailey, Nicholas Palermo, Gloria E. O. Borgstahl, Amarnath Natarajan, Srikumar M. Raja, Mayumi Naramura, Vimla Band, and Hamid Band, “Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl -family ubiquitin ligases,” Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1833, no. 1, pp. 122–139, 2013. View at Publisher · View at Google Scholar
  • Abhijeet Kulkarni, and Jayanta K. Pal, “Small molecule modulators of eukaryotic initiation factor 2 alpha kinases, the key regulators of protein synthesis,” Biochimie, vol. 95, no. 11, pp. 1980–1990, 2013. View at Publisher · View at Google Scholar
  • Sascha Dietrich, Christine S. Falk, Axel Benner, Suzan Karamustafa, Esther Hahn, Mindaugas Andrulis, Ute Hegenbart, Anthony D. Ho, Peter Dreger, and Thomas Luft, “Endothelial Vulnerability and Endothelial Damage Are Associated with Risk o f Graft-versus-Host Disease and Response to Steroid Treatment,” Biology of Blood and Marrow Transplantation, vol. 19, no. 1, pp. 22–27, 2013. View at Publisher · View at Google Scholar
  • Yeon Joo Lee, Dick Chung, Kun Xiao, Esperanza B. Papadopoulos, Juliet N. Barker, Trudy N. Small, Sergio A. Giralt, Junting Zheng, Ann A. Jakubowski, and Genovefa A. Papanicolaou, “Adenovirus Viremia and Disease: Comparison of T Cell-Depleted and Conventio nal Hematopoietic Stem Cell Transplantation Recipients from a Single Instit ution,” Biology of Blood and Marrow Transplantation, vol. 19, no. 3, pp. 387–392, 2013. View at Publisher · View at Google Scholar
  • Stanley R. Riddell, Michael C. Jensen, and Carl H. June, “Chimeric Antigen Receptor-Modified T Cells: Clinical Translation in Stem Ce ll Transplantation and Beyond,” Biology of Blood and Marrow Transplantation, vol. 19, no. 1, pp. S2–S5, 2013. View at Publisher · View at Google Scholar
  • Cinja Sukdolak, Sabine Tischer, Dania Dieks, Constanca Figueiredo, Lilia Goudeva, Hans-Gent Heuft, Murielle Verboom, Stephan Immenschuh, Albert Heim, Sylvia Borchers, Eva Mischak-Weissinger, Rainer Blasczyk, and Britta Maecker-Kolhoff, “CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Po tential Third-Party Donors to Improve Post-Transplantation Outcome,” Biology of Blood and Marrow Transplantation, vol. 19, no. 10, pp. 1480–1492, 2013. View at Publisher · View at Google Scholar
  • Martino Introna, Giovanna Lucchini, Erica Dander, Stefania Galimberti, Attilio Rovelli, Adriana Balduzzi, Daniela Longoni, Fabio Pavan, Francesca Masciocchi, Alessandra Algarotti, Caterina Micò, Anna Grassi, Sara Deola, Irene Cavattoni, Giuseppe Gaipa, Daniela Belotti, Paolo Perseghin, Matteo Parma, Enrico Pogliani, Josee Golay, Olga Pedrini, Chiara Capelli, Sergio Cortelazzo, Giovanna D’Amico, Andrea Biondi, Alessandro Rambaldi, and Ettore Biagi, “Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients,” Biology of Blood and Marrow Transplantation, 2013. View at Publisher · View at Google Scholar
  • Lenka Humplikova, Sona Kollinerova, Tomas Papajik, Zuzana Pikalova, Milena Holzerova, Vit Prochazka, Martina Divoka, Martin Modriansky, and Karel Indrak, “Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leu kemia,” Biomedical Papers-Olomouc, vol. 157, no. 4, pp. 284–293, 2013. View at Publisher · View at Google Scholar
  • Janaína Souza Ventura, Fernanda Faria, Isabel Fátima Correia Batista, Simone Michaela Simons, Daniella Gorete Lourenço Oliveira, Katia L.P. Morais, and Ana Marisa Chudzinski-Tavassi, “A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis,” Biomedicine and Pharmacotherapy, vol. 67, no. 3, pp. 192–196, 2013. View at Publisher · View at Google Scholar
  • Shi Wang, Norio Shimizu, Siok-Bian Ng, Jim Liang-Seah Tay, Junli Yan, Gaofeng Huang, Qiang Yu, Viknesvaran Selvarajan, Chonglei Bi, Baohong Lin, Shaw-Cheng Liu, Shoa-Nian Choo, Tze Loong Koh, and Joy Tan, “EZH2 overexpression in natural killer/T-cell lymphoma confers growth advant age independently of histone methyltransferase activity,” Blood, vol. 121, no. 22, pp. 4512–4520, 2013. View at Publisher · View at Google Scholar
  • Mario Cazzola, Marianna Rossi, and Luca Malcovati, “Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms,” Blood, vol. 121, no. 2, pp. 260–269, 2013. View at Publisher · View at Google Scholar
  • Peter Kraft, Guido Stoll, Martina Morowski, Timo Voegtle, and Christoph Kleinschnitz, “Only severe thrombocytopenia results in bleeding and defective thrombus for mation in mice,” Blood, vol. 121, no. 24, pp. 4938–4947, 2013. View at Publisher · View at Google Scholar
  • V. I. Gaidzik, R. F. Schlenk, P. Paschka, A. Stolzle, D. Spath, A. Kuendgen, M. von Lilienfeld-Toal, W. Brugger, H. G. Derigs, S. Kremers, R. Greil, A. Raghavachar, M. Ringhoffer, H. R. Salih, M. Wattad, H. G. Kirchen, V. Runde, G. Heil, A. L. Petzer, M. Girschikofsky, M. Heuser, S. Kayser, G. Goehring, M.-V. Teleanu, B. Schlegelberger, A. Ganser, J. Krauter, L. Bullinger, H. Dohner, and K. Dohner, “Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG),” Blood, vol. 121, no. 23, pp. 4769–4777, 2013. View at Publisher · View at Google Scholar
  • Armen Mardiros, Cedric Dos Santos, Tinisha McDonald, Christine E. Brown, Xiuli Wang, L. Elizabeth Budde, Lauren Hoffman, Brenda Aguilar, Wen-Chung Chang, William Bretzlaff, Brenda Chang, Mahesh Jonnalagadda, Renate Starr, Julie R. Ostberg, Michael C. Jensen, and Ravi Bhatia, “T cells expressing CD123-specific chimeric antigen receptors exhibit specif ic cytolytic effector functions and antitumor effects against human acute m yeloid leukemia,” Blood, vol. 122, no. 18, pp. 3138–3148, 2013. View at Publisher · View at Google Scholar
  • L. J. Costa, A. C. Xavier, A. E. Wahlquist, and E. G. Hill, “Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases,” Blood, vol. 121, no. 24, pp. 4861–4866, 2013. View at Publisher · View at Google Scholar
  • A. Huttenlocher, “ECM: chemoattraction but not adhesion,” Blood, vol. 121, no. 9, pp. 1489–1491, 2013. View at Publisher · View at Google Scholar
  • Mignon L. Loh, Sarah K. Tasian, Julie Weng, John K. Choi, Deborah L. French, Chiaka Aribeana, Silvia Bresolin, Shilpa Gandre-Babbe, Helene Favre, Prasuna Paluru, Lin Lu, Stella T. Chou, and Spencer K. Sullivan, “Patient-derived induced pluripotent stem cells recapitulate hematopoietic a bnormalities of juvenile myelomonocytic leukemia,” Blood, vol. 121, no. 24, pp. 4925–4929, 2013. View at Publisher · View at Google Scholar
  • Yiming Xu, Weizhen Wu, Liangsu Wang, Madhu Chintala, Andrew S. Plump, Martin L. Ogletree, and Zhu Chen, “Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro,” Blood Coagulation and Fibrinolysis, vol. 24, no. 3, pp. 332–338, 2013. View at Publisher · View at Google Scholar
  • Jia-Jia Huang, Ya-Jun Li, Yi Xia, Yu Wang, Wen-Xiao Wei, Ying-Jie Zhu, Tong-Yu Lin, Hui-Qiang Huang, Wen-Qi Jiang, and Zhi-Ming Li, “Prognostic significance of peripheral monocyte count in patients with extra nodal natural killer/T-cell lymphoma,” Bmc Cancer, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Anita Ordas, Zakia Kanwal, Valesca Lindenberg, Julien Rougeot, Matyas Mink, and Herman P. Spaink, “MicroRNA-146 function in the innate immune transcriptome response of zebraf ish embryos to Salmonella typhimurium infection,” Bmc Genomics, vol. 14, 2013. View at Publisher · View at Google Scholar
  • Hassan A. Al-Jafar, Nadia Abul, Niranjan Kumar, and Adel Al-Awadhi, “Can lenalidomide play a role in the management of scleritis?,” BMJ Case Reports, 2013. View at Publisher · View at Google Scholar
  • S. O. Ahmed, A. Sureda, and M. Aljurf, “The role of hematopoietic SCT in adult Burkitt lymphoma,” Bone Marrow Transplantation, vol. 48, no. 5, pp. 617–629, 2013. View at Publisher · View at Google Scholar
  • S G Papageorgiou, K Cwynarski, and P D Kottaridis, “The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL),” Bone Marrow Transplantation, 2013. View at Publisher · View at Google Scholar
  • G Kunter, J B Perkins, J Pidala, T Nishihori, M A Kharfan-Dabaja, T Field, H Fernandez, L Perez, F Locke, E Ayala, M Tomblyn, J L Ochoa-Bayona, B Betts, M Nieder, and C Anasetti, “Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission,” Bone Marrow Transplantation, 2013. View at Publisher · View at Google Scholar
  • Q. Cai, X. Luo, Y. Liang, H. Rao, X. Fang, W. Jiang, T. Lin, T. Lin, and H. Huang, “Fasting blood glucose is a novel prognostic indicator for extranodal natura l killer/T-cell lymphoma, nasal type,” British Journal of Cancer, vol. 108, no. 2, pp. 380–386, 2013. View at Publisher · View at Google Scholar
  • Anamarija M. Perry, David Crockett, Bhavana J. Dave, Pamela Althof, Lisa Winkler, Lynette M. Smith, Patricia Aoun, Wing C. Chan, Kai Fu, Timothy C. Greiner, Phillip Bierman, Robert Gregory Bociek, Julie M. Vose, James O. Armitage, and Dennis D. Weisenburger, “B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases,” British Journal of Haematology, 2013. View at Publisher · View at Google Scholar
  • Alan D. Ramsay, and Manuel Rodriguez-Justo, “Chronic lymphocytic leukaemia - the role of the microenvironment pathogenesis and therapy,” British Journal of Haematology, 2013. View at Publisher · View at Google Scholar
  • Ophira Salomon, and Nurit Rosenberg, “Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia,” British Journal of Haematology, 2013. View at Publisher · View at Google Scholar
  • Graham P. Collins, Anne N. Parker, Christopher Pocock, Irfan Kayani, Anna Sureda, Tim Illidge, Kirit Ardeshna, David C. Linch, and Karl S. Peggs, “Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma,” British Journal of Haematology, 2013. View at Publisher · View at Google Scholar
  • Robin E. Gasiorowski, Georgina J. Clark, Kenneth Bradstock, and Derek N. J. Hart, “Antibody therapy for acute myeloid leukaemia,” British Journal of Haematology, vol. 164, no. 4, pp. 481–495, 2013. View at Publisher · View at Google Scholar
  • Brígida R Pinho, Miguel M Santos, Anabela Fonseca-Silva, Patrícia Valentão, Paula B Andrade, and Jorge M A Oliveira, “ How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs ,” British Journal of Pharmacology, vol. 169, no. 5, pp. 1072–1090, 2013. View at Publisher · View at Google Scholar
  • C. C. Chang, H. C. Chang, C. H. Wu, C. Y. Chang, C. C. Liao, and T. L. Chen, “Adverse postoperative outcomes in surgical patients with immune thrombocyto penia,” British Journal of Surgery, vol. 100, no. 5, pp. 684–692, 2013. View at Publisher · View at Google Scholar
  • María Cecilia D’Anna, and Marta Elena Roque, “Physiological focus on the erythropoietin–hepcidin–ferroportin axis,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 5, pp. 338–345, 2013. View at Publisher · View at Google Scholar
  • Alexander J. Ambinder, Pareen J. Shenoy, Loretta J. Nastoupil, and Christopher R. Flowers, “Using primary site as a predictor of survival in mantle cell lymphoma,” Cancer, vol. 119, no. 8, pp. 1570–1577, 2013. View at Publisher · View at Google Scholar
  • Josep-Maria Ribera, Olga Garcia, Carlos Grande, Jordi Esteve, Albert Oriol, Juan Bergua, Jose Gonzalez-Campos, Ferran Vall-Ilovera, Mar Tormo, Jesus-Maria Hernandez-Rivas, Daniel Garcia, Salut Brunet, Natalia Alonso, Pere Barba, Pilar Miralles, Andreu Llorente, Pau Montesinos, Maria-Jose Moreno, Jose-Angel Hernandez-Rivas, and Teresa Bernal, “Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Ly mphoma Regardless of Human Immunodeficiency Virus Infection Status Final Re sults of a Phase 2 Study (Burkimab),” Cancer, vol. 119, no. 9, pp. 1660–1668, 2013. View at Publisher · View at Google Scholar
  • William McClellan, Kevin Ward, Loretta J. Nastoupil, Lance Waller, Catherine Bulka, Alexander Ambinder, Adrienne Phillips, A. Rana Bayakly, and Jeffrey M. Switchenko, “Residence proximity to benzene release sites is associated with increased i ncidence of non-Hodgkin lymphoma,” Cancer, vol. 119, no. 18, pp. 3309–3317, 2013. View at Publisher · View at Google Scholar
  • Eric S. Winer, and Adam J. Olszewski, “Population-Based Prognostic Factors for Survival in Patients With Burkitt L ymphoma,” Cancer, vol. 119, no. 20, pp. 3672–3679, 2013. View at Publisher · View at Google Scholar
  • Katja Karjalainen, Renata Pasqualini, Jorge E. Cortes, Steven M. Kornblau, Benjamin Lichtiger, Susan O'Brien, Hagop M. Kantarjian, Richard L. Sidman, Wadih Arap, and Erkki Koivunen, “Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia,” Cancer, 2013. View at Publisher · View at Google Scholar
  • Stefan Stefanovic, Florian Schuetz, Christof Sohn, Philipp Beckhove, and Christoph Domschke, “Adoptive immunotherapy of metastatic breast cancer: present and future,” Cancer and Metastasis Reviews, 2013. View at Publisher · View at Google Scholar
  • Christos Patsis, Dimitra Florou, and Alexandros Ardavanis, “Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cel ls,” Cancer Biology & Therapy, vol. 14, no. 7, pp. 587–596, 2013. View at Publisher · View at Google Scholar
  • Rob A. Cairns, “Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clini cal Opportunities,” Cancer Discovery, vol. 3, no. 7, pp. 730–741, 2013. View at Publisher · View at Google Scholar
  • Adam M. Mendizabal, Pat Garcia-Gonzalez, and Paul H. Levine, “Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries,” Cancer Epidemiology, vol. 37, no. 3, pp. 247–254, 2013. View at Publisher · View at Google Scholar
  • Chih-Shin Lin, Charlene Lin, Shih-Feng Weng, and Shih-Wei Lin, “Cancer survival in patients with HIV/AIDS in the era of highly active antir etroviral therapy in Taiwan: A population-based cohort study,” Cancer Epidemiology, vol. 37, no. 5, pp. 719–724, 2013. View at Publisher · View at Google Scholar
  • Huan Shi, Lin Liu, and Zhehai Wang, “Improving the efficacy and safety of engineered T cell therapy for cancer,” Cancer Letters, vol. 328, no. 2, pp. 191–197, 2013. View at Publisher · View at Google Scholar
  • M. Schlienger, J. -P. Ferroir, F. Huguet, F. Deluen, F. Pene, R. Marseguerra, and E. Touboul, “Dropped Head Syndrome after whiplash injury in a patient treated for a Hodg kin's lymphoma by mantle field radiotherapy,” Cancer Radiotherapie, vol. 17, no. 1, pp. 44–49, 2013. View at Publisher · View at Google Scholar
  • Mariano Provencio, Antonio Sánchez, and Margarita Sánchez-Beato, “New drugs and targeted treatments in Hodgkin’s lymphoma,” Cancer Treatment Reviews, 2013. View at Publisher · View at Google Scholar
  • Joanna Saluk, Michal Bijak, Michal Blazej Ponczek, Pawel Nowak, and Barbara Wachowicz, “(1→3)-β-D-glucan reduces the damages caused by reactive oxygen species induced in human platelets by lipopolysaccharides,” Carbohydrate Polymers, 2013. View at Publisher · View at Google Scholar
  • K. Masui, B. Gini, J. Wykosky, C. Zanca, P. S. Mischel, F. B. Furnari, and W. K. Cavenee, “A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments,” Carcinogenesis, vol. 34, no. 4, pp. 725–738, 2013. View at Publisher · View at Google Scholar
  • Peter Clemmensen, Nadia Paarup Dridi, and Lene Holmvang, “Dual Antiplatelet Therapy with Prasugrel or Ticagrelor Versus Clopidogrel i n Interventional Cardiology,” Cardiovascular Drugs and Therapy, vol. 27, no. 3, pp. 239–245, 2013. View at Publisher · View at Google Scholar
  • Rafaela Elvira Rozza-de-Menezes, Stefânia Jeronimo Ferreira, Diogo Lenzi Capella, Stephan Schwartz, Ana Helena Willrich, Lúcia de Noronha, Aline Cristina Batista Rodrigues Johann, and Paulo Henrique Couto Souza, “Gingival Anaplastic Large-Cell Lymphoma Mimicking Hyperplastic Benignancy as the First Clinical Manifestation of AIDS: A Case Report and Review of the Literature,” Case Reports in Dentistry, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Ambra Di Veroli, Alessandro Micarelli, Mariagiovanna Cefalo, Eleonora Ceresoli, Daniela Nasso, Laura Cicconi, Simone Mauramati, Fabrizio Ottaviani, Adriano Venditti, and Sergio Amadori, “Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge,” Case Reports in Hematology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • David M. Weingeist, Jing Ge, David K. Wood, James T. Mutamba, Qiuying Huang, Elizabeth A. Rowland, Michael B. Yaffe, Scott Floyd, and Bevin P. Engelward, “Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors,” Cell Cycle, vol. 12, no. 6, pp. 907–915, 2013. View at Publisher · View at Google Scholar
  • Yang, Chen, Wu, Cheng, Lin, Cheng, Ho, Lo, and Chiu, “Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans,” Cell Death and Disease, vol. 4, no. 5, 2013. View at Publisher · View at Google Scholar
  • Brian Henderson, “Do reciprocal interactions between cell stress proteins and cytokines creat e a new intra-/extra-cellular signalling nexus?,” Cell Stress & Chaperones, vol. 18, no. 6, pp. 685–701, 2013. View at Publisher · View at Google Scholar
  • Carmen Fiuza-Luces, Africa Gonzalez-Murillo, Luisa Soares-Miranda, Jesus Martinez Palacio, Isabel Colmenero, Fernando Casco, Gustavo Melen, Maria Moran, and Manuel Ramirez, “Effects of Exercise Interventions in Graft-Versus-Host Disease Models,” Cell Transplantation, vol. 22, no. 12, pp. 2409–2420, 2013. View at Publisher · View at Google Scholar
  • Janesh Pillay, Tamar Tak, and Vera M. Kamp, “Immune suppression by neutrophils and granulocytic myeloid-derived suppress or cells: similarities and differences,” Cellular And Molecular Life Sciences, vol. 70, no. 20, pp. 3813–3827, 2013. View at Publisher · View at Google Scholar
  • Igor M. Samokhvalov, “Deconvoluting the ontogeny of hematopoietic stem cells,” Cellular and Molecular Life Sciences, vol. 71, no. 6, pp. 957–978, 2013. View at Publisher · View at Google Scholar
  • Federica Rizzo, Giulietta Riboldi, Sabrina Salani, Monica Nizzardo, Chiara Simone, Stefania Corti, and Eva Hedlund, “Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis,” Cellular and Molecular Life Sciences, 2013. View at Publisher · View at Google Scholar
  • Xue-Feng Jin, Ning Wu, Lv Wang, and Jin Li, “Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases,” Cellular And Molecular Neurobiology, vol. 33, no. 5, pp. 601–613, 2013. View at Publisher · View at Google Scholar
  • Juan Liu, Chun Qiao, Jian-Fu Zhang, Jian-Yong Li, Run Zhang, Zheng Ge, Zhong-Kun Lin, Ping Liu, Hai-Rong Qiu, Guang-Rong Zhu, Hui Yang, and Yu-Jie Wu, “Genetic characteristics and its prognostic significance for 217 adult patients with acute lymphoblastic leukemia,” Chinese Journal of Medical Genetics, vol. 30, no. 2, pp. 129–133, 2013. View at Publisher · View at Google Scholar